Amazit Larbi, Roseau Audrey, Khan Junaid A, Chauchereau Anne, Tyagi Rakesh K, Loosfelt Hugues, Leclerc Philippe, Lombès Marc, Guiochon-Mantel Anne
Institut National de la Santé et de la Recherche Médicale Unité 693, 63 Rue Gabriel Péri, Le Kremlin-Bicêtre F-94276, France.
Mol Endocrinol. 2011 Mar;25(3):394-408. doi: 10.1210/me.2010-0458. Epub 2011 Jan 27.
The progesterone receptor (PR), a ligand-activated transcription factor, recruits the primary coactivator steroid receptor coactivator-1 (SRC-1) gene promoters. It is known that PR transcriptional activity is paradoxically coupled to its ligand-dependent down-regulation. However, despite its importance in PR function, the regulation of SRC-1 expression level during hormonal exposure is poorly understood. Here we report that SRC-1 expression level (but not other p160 family members) is down-regulated by the agonist ligand R5020 in a PR-dependent manner. In contrast, the antagonist RU486 fails to induce down-regulation of the coactivator and impairs PR agonist-dependent degradation of SRC-1. We show that SRC-1 proteolysis is a proteasome- and ubiquitin-mediated process that, predominantly but not exclusively, occurs in the cytoplasmic compartment in which SRC-1 colocalizes with proteasome antigens as demonstrated by confocal imaging. Moreover, SRC-1 was stabilized in the presence of leptomycin B or several proteasomal inhibitors. Two degradation motifs, amino-acids 2-16 corresponding to a PEST motif and amino acids 41-136 located in the basic helix loop helix domain of the coactivator, were identified and shown to control the stability as well as the hormone-dependent down-regulation of the coactivator. SRC-1 degradation is of physiological importance because the two nondegradable mutants that still interacted with PR as demonstrated by coimmunoprecipitation failed to stimulate transcription of exogenous and endogenous target genes, suggesting that concomitant PR/SRC-1 ligand-dependent degradation is a necessary step for PR transactivation activity. Collectively our findings are consistent with the emerging role of proteasome-mediated proteolysis in the gene-regulating process and indicate that the ligand-dependent down-regulation of SRC-1 is critical for PR transcriptional activity.
孕激素受体(PR)是一种配体激活的转录因子,可募集主要的共激活因子类固醇受体共激活因子-1(SRC-1)基因启动子。已知PR转录活性与其配体依赖性下调存在矛盾关联。然而,尽管SRC-1在PR功能中很重要,但在激素暴露期间其表达水平的调节却知之甚少。在此我们报告,激动剂配体R5020以PR依赖性方式下调SRC-1的表达水平(而非其他p160家族成员)。相反,拮抗剂RU486未能诱导共激活因子的下调,并损害PR激动剂依赖性的SRC-1降解。我们表明,SRC-1的蛋白水解是一个蛋白酶体和泛素介导的过程,主要但并非唯一地发生在细胞质区室中,共聚焦成像显示SRC-1与蛋白酶体抗原共定位。此外,在存在 leptomycin B 或几种蛋白酶体抑制剂的情况下,SRC-1 得以稳定。鉴定出两个降解基序,对应于PEST基序的氨基酸2 - 16以及位于共激活因子基本螺旋-环-螺旋结构域中的氨基酸41 - 136,它们控制着共激活因子的稳定性以及激素依赖性下调。SRC-1降解具有生理重要性,因为通过免疫共沉淀证明仍与PR相互作用的两个不可降解突变体未能刺激外源和内源靶基因的转录,这表明PR/SRC-1配体依赖性的同时降解是PR反式激活活性的必要步骤。总体而言,我们的发现与蛋白酶体介导的蛋白水解在基因调控过程中日益凸显的作用一致,并表明SRC-1的配体依赖性下调对PR转录活性至关重要。